We are live on ! Find out more
GEA

Glen Eagle Advisors Portfolio holdings

AUM $714M
1-Year Est. Return 18.87%
This Fund
S&P 500
This Quarter Est. Return
+7.34%
1 Year Est. Return
+18.87%
3 Year Est. Return
+62.99%
5 Year Est. Return
+76.32%
10 Year Est. Return
AUM
$322M
AUM Growth
+$35.3M
Cap. Flow
+$17M
Cap. Flow %
5.28%
Top 10 Hldgs %
30.83%
Holding
1,070
New
67
Increased
247
Reduced
122
Closed
30

Sector Composition

Rank Sector Weight
1 Technology 12.22%
2 Healthcare 10.01%
3 Financials 6.51%
4 Consumer Discretionary 4.83%
5 Communication Services 4.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IDNA icon
601
iShares Genomics Immunology and Healthcare ETF
IDNA
$189M
$15.6K ﹤0.01%
300
VOD icon
602
Vodafone
VOD
$35B
$15.6K ﹤0.01%
911
GGN
603
GAMCO Global Gold, Natural Resources & Income Trust
GGN
$764M
$15.6K ﹤0.01%
3,900
LGO
604
Largo
LGO
$63M
$15.6K ﹤0.01%
+1,000
New +$15.8K
AAL icon
605
American Airlines Group
AAL
$9.47B
$15.5K ﹤0.01%
732
-40
-5% -$905
BEAM icon
606
Beam Therapeutics
BEAM
$2.59B
$15.4K ﹤0.01%
120
SPHB icon
607
Invesco S&P 500 High Beta ETF
SPHB
$962M
$15.1K ﹤0.01%
200
VT icon
608
Vanguard Total World Stock ETF
VT
$76.2B
$15K ﹤0.01%
145
+1
+0.7% +$102
LUMN icon
609
Lumen
LUMN
$6.53B
$14.9K ﹤0.01%
1,100
STM icon
610
STMicroelectronics
STM
$45.8B
$14.9K ﹤0.01%
410
NSC icon
611
Norfolk Southern
NSC
$79.1B
$14.9K ﹤0.01%
56
IETC icon
612
iShares US Tech Independence Focused ETF
IETC
$720M
$14.9K ﹤0.01%
271
SPAB icon
613
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.78B
$14.9K ﹤0.01%
495
SJM icon
614
J.M. Smucker
SJM
$12.6B
$14.8K ﹤0.01%
115
+9
+8% +$1.2K
IBB icon
615
iShares Biotechnology ETF
IBB
$9.32B
$14.8K ﹤0.01%
91
MFL
616
DELISTED
BLACKROCK MUNIHOLDINGS INVESTMENT QUALITY FUND
MFL
$14.8K ﹤0.01%
1,000
KBA icon
617
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$149M
$14.6K ﹤0.01%
305
SLQD icon
618
iShares 0-5 Year Investment Grade Corporate Bond ETF
SLQD
$2.36B
$14.5K ﹤0.01%
280
IWS icon
619
iShares Russell Mid-Cap Value ETF
IWS
$15.7B
$14.5K ﹤0.01%
+126
New +$14.4K
GBDC icon
620
Golub Capital BDC
GBDC
$3.33B
$14.4K ﹤0.01%
935
+17
+2% +$264
IUSB icon
621
iShares Core Universal USD Bond ETF
IUSB
$42.6B
$14.4K ﹤0.01%
+269
New +$14.3K
DHR.PRA
622
DELISTED
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
$14.4K ﹤0.01%
8
CHI
623
Calamos Convertible Opportunities and Income Fund
CHI
$1.02B
$14.3K ﹤0.01%
945
+18
+2% +$269
SPTL icon
624
State Street SPDR Portfolio Long Term Treasury ETF
SPTL
$10.5B
$14.3K ﹤0.01%
347
-66
-16% -$2.64K
OKE icon
625
Oneok
OKE
$58.8B
$14K ﹤0.01%
251

Similar funds

Glen Eagle Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, Glen Eagle Advisors held 1,070 positions worth $322M, up 12% from $286M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Glen Eagle Advisors deployed $17M of net new capital in Q2 2021, opening 67 new positions and adding to 247 existing holdings. Its largest new stake was Dimensional US Core Equity 2 ETF: 10,640 shares worth $287K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was iShares AAA-A Rated Corporate Bond ETF, an estimated $3.37M trimmed.

  • Glen Eagle Advisors's largest Q2 2021 buy was Dimensional US Core Equity 2 ETF: 10,640 shares worth $287K.
  • Glen Eagle Advisors added most to iShares 1-5 Year Investment Grade Corporate Bond ETF in Q2 2021, an estimated $2.53M increase.
  • Glen Eagle Advisors's biggest Q2 2021 reduction was iShares AAA-A Rated Corporate Bond ETF, cutting an estimated $3.37M.
  • Glen Eagle Advisors fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $26.9K.
  • Glen Eagle Advisors's ten largest holdings make up 31% of its $322M portfolio in Q2 2021.
  • Glen Eagle Advisors opened 67 new positions and closed 30 in Q2 2021.
  • Glen Eagle Advisors's portfolio value rose 12% quarter-over-quarter to $322M.

Based on Glen Eagle Advisors's 13F filing for Q2 2021, filed 13 Aug 2024.